Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism
Arthur L. Burnett(Johns Hopkins University), Biljana Musicki(Johns Hopkins University), Trinity J. Bivalacqua(University of Pennsylvania), Hunter C. Champion(Southeastern University)
Cited by 127
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Priapism: Pathogenesis, Epidemiology, and Management
|The Journal of Sexual Medicine|2010|401
Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection
|Proceedings of the National Academy of Sciences|2002|377
RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction
|Proceedings of the National Academy of Sciences|2004|316